WED Fundamental Analysis - WESTAIM CORP/THE

Fundamental Rating

Overall WED gets a fundamental rating of 3 out of 10. We evaluated WED against 81 industry peers in the Capital Markets industry. The financial health of WED is average, but there are quite some concerns on its profitability. WED is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year WED has reported negative net income.
WED had a negative operating cash flow in the past year.
In multiple years WED reported negative net income over the last 5 years.
WED had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -5.01%, WED is doing worse than 83.75% of the companies in the same industry.
Looking at the Return On Equity, with a value of -6.04%, WED is doing worse than 80.00% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-5.01%
ROE	-6.04%
ROIC	N/A

ROA(3y)11.53%

ROA(5y)6.5%

ROE(3y)12.4%

ROE(5y)6.91%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 51.72%, WED is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
In the last couple of years the Gross Margin of WED has grown nicely.
The Profit Margin and Operating Margin are not available for WED so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	51.72%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y87.02%

GM growth 5Y4.75%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for WED has been reduced compared to 1 year ago.
The number of shares outstanding for WED has been reduced compared to 5 years ago.
WED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 3.13 indicates that WED is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.13, WED is doing good in the industry, outperforming 72.50% of the companies in the same industry.
WED has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, WED is in the better half of the industry, outperforming 78.75% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	3.13

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 6.06 indicates that WED has no problem at all paying its short term obligations.
WED has a Current ratio of 6.06. This is in the better half of the industry: WED outperforms 80.00% of its industry peers.
WED has a Quick Ratio of 6.06. This indicates that WED is financially healthy and has no problem in meeting its short term obligations.
WED's Quick ratio of 6.06 is fine compared to the rest of the industry. WED outperforms 80.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	6.06
Quick Ratio	6.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

WED shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -199.93%.
The Revenue has grown by 133.78% in the past year. This is a very strong growth!
Measured over the past years, WED shows a quite strong growth in Revenue. The Revenue has been growing by 13.18% on average per year.

EPS 1Y (TTM)-199.93%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-536.56%

Revenue 1Y (TTM)133.78%

Revenue growth 3Y93.41%

Revenue growth 5Y13.18%

Sales Q2Q%112.15%

3.2 Future

The Earnings Per Share is expected to grow by 62.19% on average over the next years. This is a very strong growth
WED is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.82% yearly.

EPS Next Y-293.33%

EPS Next 2Y-54.92%

EPS Next 3Y62.19%

EPS Next 5YN/A

Revenue Next Year43.03%

Revenue Next 2Y31.82%

Revenue Next 3Y30.82%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WED. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WED. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as WED's earnings are expected to grow with 62.19% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-54.92%

EPS Next 3Y62.19%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

WED does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

WESTAIM CORP/THE

TSX-V:WED (1/16/2026, 7:00:00 PM)

25.06

+0.14 (+0.56%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)11-13 2025-11-13/amc

Earnings (Next)03-24 2026-03-24

Inst Owners9.98%

Inst Owner ChangeN/A

Ins Owners8.25%

Ins Owner ChangeN/A

Market Cap840.76M

Revenue(TTM)32.94M

Net Income(TTM)-40.54M

Analysts84.44

Price Target45.9 (83.16%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-9.04%

Min EPS beat(2)-112.38%

Max EPS beat(2)94.29%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-22.87%

Min Revenue beat(2)-32.22%

Max Revenue beat(2)-13.52%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	18.38
P/FCF	N/A
P/OCF	N/A
P/B	0.9
P/tB	1.01
EV/EBITDA	N/A

EPS(TTM)-2.35

EYN/A

EPS(NY)-0.17

Fwd EYN/A

FCF(TTM)-1.41

FCFYN/A

OCF(TTM)-1.27

OCFYN/A

SpS1.36

BVpS27.79

TBVpS24.87

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.01%
ROE	-6.04%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	51.72%
FCFM	N/A

ROA(3y)11.53%

ROA(5y)6.5%

ROE(3y)12.4%

ROE(5y)6.91%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y87.02%

GM growth 5Y4.75%

F-Score2

Asset Turnover0.04

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	119.11%
Cap/Sales	10.67%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	6.06
Quick Ratio	6.06
Altman-Z	3.13

F-Score2

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-199.93%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-536.56%

EPS Next Y-293.33%

EPS Next 2Y-54.92%

EPS Next 3Y62.19%

EPS Next 5YN/A

Revenue 1Y (TTM)133.78%

Revenue growth 3Y93.41%

Revenue growth 5Y13.18%

Sales Q2Q%112.15%

Revenue Next Year43.03%

Revenue Next 2Y31.82%

Revenue Next 3Y30.82%

Revenue Next 5YN/A

EBIT growth 1Y-98.68%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year115.66%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-1056.2%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-937.13%

OCF growth 3YN/A

OCF growth 5YN/A

WESTAIM CORP/THE / WED.CA FAQ

Can you provide the ChartMill fundamental rating for WESTAIM CORP/THE?

ChartMill assigns a fundamental rating of 3 / 10 to WED.CA.

Can you provide the valuation status for WESTAIM CORP/THE?

ChartMill assigns a valuation rating of 1 / 10 to WESTAIM CORP/THE (WED.CA). This can be considered as Overvalued.

Can you provide the profitability details for WESTAIM CORP/THE?

WESTAIM CORP/THE (WED.CA) has a profitability rating of 1 / 10.

What is the financial health of WESTAIM CORP/THE (WED.CA) stock?

The financial health rating of WESTAIM CORP/THE (WED.CA) is 6 / 10.

WESTAIM CORP/THE (WED.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

WESTAIM CORP/THE / WED.CA FAQ

Can you provide the ChartMill fundamental rating for WESTAIM CORP/THE?

Can you provide the valuation status for WESTAIM CORP/THE?

Can you provide the profitability details for WESTAIM CORP/THE?

What is the financial health of WESTAIM CORP/THE (WED.CA) stock?